AHRQ: Agency Information Collection Activities: Proposed Collection; Comment Request
Notice from the Agency for Healthcare Research and Quality (AHRQ) allowing an additional 30 days for comments on revisions to the AHRQ Safety Program for Methicillin-ResistantStaphylococcus aureus (MRSA) Prevention. The purpose of the AHRQ Safety Program for MRSA Prevention is to reduce the incidence and prevalence of infections caused by MRSA in a variety of settings. Proposed revisions cover data collected by the ICU/Non-ICU, surgical services, and long-term care cohorts. Comments are now due by November 10, 2022.